Clinical Trial Update: Retinal Blood Flow in Response to an Intravitreal Injection of Ranibizumab for Central Retinal Vein Occlusion (CRVO)

View source ↗

Summary

This clinical trial update reports on retinal blood flow changes following an intravitreal ranibizumab injection in central retinal vein occlusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: University of Toronto | Conditions: Central Retinal Vein Occlusion | Status: UNKNOWN